Clinical Trials on CIN 2/3
Total 18364 results
-
University of OxfordNIHR Collaboration for Leadership in Applied Health Research and Care (Oxford)CompletedType 2 Diabetes MellitusUnited Kingdom
-
Kun-Ho YoonTakedaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
University of PalermoAstraZeneca; University of CataniaUnknown
-
LG Life SciencesCompleted
-
Biocon LimitedCompletedType 2 Diabetes Mellitus
-
Sun Yat-sen UniversitySuspended
-
Novartis PharmaceuticalsCompletedType-2 Diabetes MellitusHong Kong
-
Dong-A ST Co., Ltd.CompletedType 2 Diabetes MellitusKorea, Republic of
-
NovartisCompleted
-
TakedaTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
-
TakedaCompleted
-
HealthPartners InstituteAmylin Pharmaceuticals, LLC.CompletedType 2 Diabetes MellitusUnited States
-
University of ArizonaUnknownType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
Poxel SACompletedType 2 Diabetes MellitusLatvia
-
Pusan National University HospitalUnknownType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Hospital Universitario Central de AsturiasSanofiTerminated
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Completed
-
Endocrine Research SocietySuspendedType 2 Diabetes MellitusCanada
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusPoland, United Kingdom, Germany, Romania, Hungary, Denmark, Lithuania
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusChina
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
University Hospital, ToulouseCompletedType 2 Diabetes MellitusFrance
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusEgypt, United Kingdom, Turkey, Lebanon, Russian Federation, Tunisia, Malaysia, Germany, Spain, Saudi Arabia, Denmark, Indonesia, Jordan, Kuwait, Singapore, United Arab Emirates
-
SanofiCompleted
-
Maastricht University Medical CenterUnknownType 2 Diabetes MellitusNetherlands
-
TakedaCompleted
-
Tehran University of Medical SciencesCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
TakedaCompleted
-
TakedaCompleted
-
Samuel Lunenfeld Research Institute, Mount Sinai...Merck Sharp & Dohme LLCCompleted
-
JW PharmaceuticalCompleted
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
SanofiCompletedType 2 Diabetes MellitusFrance, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Spain, United Kingdom
-
Sun Yat-sen UniversityCompletedType 2 Diabetes MellitusChina
-
Postgraduate Institute of Medical Education and...Indian Council of Medical Research; International Clinical Epidemiology Network...UnknownType 2 Diabetes MellitusIndia
-
Johns Hopkins Bloomberg School of Public HealthAmerican Diabetes AssociationCompleted
-
Asahi Kasei Pharma CorporationRecruitingType 2 Diabetes MellitusChina
-
University of LiverpoolAstraZeneca; Clinical Practice Research DatalinkActive, not recruitingType 2 Diabetes MellitusUnited Kingdom
-
Regor Pharmaceuticals Inc.TerminatedType 2 Diabetes MellitusUnited States
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)Terminated
-
Endocrine Research SocietyCompletedType 2 Diabetes MellitusCanada
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, Turkey, China, Netherlands, Argentina, Austria, Czechia, United Arab Emirates, Taiwan, India, Egypt, Saudi Arabia, Lebanon, Indonesia, Col... and more